Ekso Bionics Inc.

NASDAQ: EKSO · Real-Time Price · USD
3.13
-0.06 (-1.88%)
At close: Aug 15, 2025, 3:08 PM

Ekso Bionics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.33M -15.2M -15.08M -9.76M
Depreciation & Amortization
1.61M 1.7M 887K 561K
Stock-Based Compensation
1.63M 2.24M 2.73M 2.5M
Other Working Capital
-527K 1.7M -1.01M 296K
Other Non-Cash Items
-1.75M -207K -647K 134K
Deferred Income Tax
n/a n/a n/a -4.12M
Change in Working Capital
n/a -583K -2.58M -468K
Operating Cash Flow
-9.85M -12.05M -14.69M -11.16M
Capital Expenditures
n/a -157K -194K -59K
Cash Acquisitions
n/a n/a -5M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-37K n/a 19K n/a
Investing Cash Flow
-37K -157K -5.17M -59K
Debt Repayment
-1.25M -313K n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -176K 1.42M
Financial Cash Flow
7.77M 348K 176K 38.71M
Net Cash Flow
-2.15M -11.89M -19.88M 27.54M
Free Cash Flow
-9.88M -12.21M -14.88M -11.21M